Health
Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes – News-Medical.Net
Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.
Reviewed by Emily Henderson, B.Sc.Nov 16 2020
Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.
Since that time, evidence in favor of the use of sodium/glucose cotransporter 2 (SGLT2) inhibitors has been mounting, with studies showing better blood glucose control, cardiovascular benefits, weight loss and more for patients with diabetes taking SGLT2 inhibitors.
Now, two large clinical trials, conducted by investigators at…
-
Noosa News22 hours agoPolice make emergency declaration after fire at storage facility north of Brisbane
-
General23 hours agoTassie heads to the polls as the Liberals leave the building
-
General16 hours agoPentagon launches review into AUKUS deal
-
General14 hours agoThe stark numbers that spell grim news for Aussie musos